ArticleCancer gene therapy2025

SLC34A2 inhibits tumorigenesis and progression via upregulating LRRK2/TTF-1/SELENBP1 axis in lung adenocarcinoma.

Ying Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.